SEOUL, Sept 24 (Reuters) – South Korea’s drug watchdog said on Tuesday it would seek information from relevant companies after a U.S. government announcement on Tylenol, adding that it planned to review opinions and documents they provided.
On Monday, President Donald Trump linked autism to childhood vaccine use and the use of popular pain medication Tylenol by pregnant women, elevating to the forefront of U.S. health policy claims unsupported by scientific evidence.
Sign up here.
Reporting by Hyunjoo Jin and Heekyong Yang; Editing by Clarence Fernandez